Synchronous primary XXXX : a series of cases and a review of literature.

@entity1 @entity43 @entity1204 @entity3556 @entity5 @entity4348
@entity5 account for 0.7-1.8% of all gynecologic @entity5 . Among them, @entity43 are predominant (40-53%). @entity1 with @entity5 have better prognosis than those with single disseminated @entity5 . We present 10 @entity1 with @entity43 who were treated at the Chemotherapy Department of the Medical University of Lodz in 2009-2013. The most often reported symptom of the disease was @entity3556 (6 @entity1 ). The range of the @entity1 ' age was 48-62 and the median age was 56. Five @entity1 had stage I of @entity43 , single @entity1 had stage IIA, IIB and IIIB, 2 @entity1 had stage IIIC. Three @entity1 had I, 5 - II, and 2 - III stage of @entity1204 . All @entity1 had endometrioid type of @entity1204 , 7 of them had also the same histological type of @entity43 . All @entity1 had adjuvant chemotherapy because of @entity43 , none of them had adjuvant radiotherapy. One @entity1 was lost to follow up. For other @entity1 a median follow up was 13 months (range: 3-53 months). One @entity1 experienced relapse, all @entity1 are alive. @entity43 are usually diagnosed at an earlier stage, have lower histological grade and better prognosis than @entity5 . The most common histological type of both @entity43 is @entity4348 . The first symptoms reported by our @entity1 and the course of the disease were concordant with data from the literature.
